Centric Services For News Today

CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.

According to the Alzheimer’s association, in 2022 approximately 6.5 million Americans are living with Alzheimer’s disease.

Chronic obstructive pulmonary disease is a group of progressive chronic inflammatory lung conditions that cause breathing difficulties.

The results could help health professionals and policymakers plan interventions for the most vulnerable diabetic CVD patients.

We analyse the impact of the war on the clinical trial landscapes of Ukraine and Russia, as investigators chronicle the situation on the ground.

MGC Pharma has obtained the South African Health Products Regulatory Authority approval for Phase IIb trial of CimetrA in Covid-19 patients.

Middle East & Africa witnessed a 6.7% rises in IT hiring activity in the pharma industry in June 2022, according to GlobalData’s Job Analytics index

Germany’s pharma industry registered a 9.9% drops in IT hiring activity in June 2022, according to GlobalData

Coronary artery disease is expected to impact roughly 13.1 million individuals over the age of 19 in the US this year.

AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.